AI Agent Elevates Disease Management with Guideline-Grounded Conversations

A new LLM-based agent, AMIE, grounds its multi-visit disease-management reasoning in up-to-date clinical guidelines and drug formularies, and in OSCE-style testing it was non-inferior to primary care physicians while outperforming them on precision and guideline alignment; a RxQA benchmark shows AMIE handles harder medication questions better, marking a notable step toward conversational AI as a medical management tool, pending further real-world validation.